vs

Side-by-side financial comparison of SeaStar Medical Holding Corp (ICU) and Planet Green Holdings Corp. (PLAG). Click either name above to swap in a different company.

Planet Green Holdings Corp. is the larger business by last-quarter revenue ($521.7K vs $420.0K, roughly 1.2× SeaStar Medical Holding Corp). On growth, SeaStar Medical Holding Corp posted the faster year-over-year revenue change (526.9% vs -36.7%).

ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, a...

Planet 13 Holdings, Inc. is a cannabis company based in Nevada, United States. On Nov 1, 2018, the company opened its cannabis dispensary in Las Vegas which became the largest cannabis dispensary in the world at 112,000 square feet.

ICU vs PLAG — Head-to-Head

Bigger by revenue
PLAG
PLAG
1.2× larger
PLAG
$521.7K
$420.0K
ICU
Growing faster (revenue YoY)
ICU
ICU
+563.5% gap
ICU
526.9%
-36.7%
PLAG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ICU
ICU
PLAG
PLAG
Revenue
$420.0K
$521.7K
Net Profit
$-2.9M
Gross Margin
97.1%
1.8%
Operating Margin
-718.6%
Net Margin
-691.4%
Revenue YoY
526.9%
-36.7%
Net Profit YoY
34.3%
-296.7%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICU
ICU
PLAG
PLAG
Q4 25
$420.0K
$521.7K
Q3 25
$183.0K
$771.6K
Q2 25
$338.0K
$907.0K
Q1 25
$293.0K
$840.3K
Q4 24
$67.0K
$823.5K
Q3 24
$68.0K
$1.5M
Q2 24
$0
$904.1K
Q1 24
$0
$1.5M
Net Profit
ICU
ICU
PLAG
PLAG
Q4 25
$-2.9M
Q3 25
$-3.5M
$-12.1M
Q2 25
$-2.0M
$-773.6K
Q1 25
$-3.8M
$-796.9K
Q4 24
$-4.4M
Q3 24
$-4.5M
$-1.2M
Q2 24
$-3.2M
$-1.7M
Q1 24
$-12.7M
$-1.1M
Gross Margin
ICU
ICU
PLAG
PLAG
Q4 25
97.1%
1.8%
Q3 25
92.3%
3.7%
Q2 25
92.0%
0.9%
Q1 25
100.0%
6.5%
Q4 24
100.0%
17.0%
Q3 24
100.0%
6.6%
Q2 24
Q1 24
23.5%
Operating Margin
ICU
ICU
PLAG
PLAG
Q4 25
-718.6%
Q3 25
-1955.7%
-435.0%
Q2 25
-519.5%
-75.9%
Q1 25
-1304.4%
-85.3%
Q4 24
-7114.9%
Q3 24
-6552.9%
-27.7%
Q2 24
-105.0%
Q1 24
-38.7%
Net Margin
ICU
ICU
PLAG
PLAG
Q4 25
-691.4%
Q3 25
-1897.3%
-1574.4%
Q2 25
-592.3%
-85.3%
Q1 25
-1287.4%
-94.8%
Q4 24
-6595.5%
Q3 24
-6585.3%
-81.1%
Q2 24
-190.3%
Q1 24
-71.9%
EPS (diluted)
ICU
ICU
PLAG
PLAG
Q4 25
Q3 25
Q2 25
$-0.18
Q1 25
$-0.44
Q4 24
$0.23
Q3 24
$-1.10
Q2 24
$-1.03
Q1 24
$-4.73
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICU
ICU
PLAG
PLAG
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
Stockholders' EquityBook value
$10.4M
$-2.2M
Total Assets
$14.2M
$10.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICU
ICU
PLAG
PLAG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$227.5K
Q2 24
$539.7K
Q1 24
Total Debt
ICU
ICU
PLAG
PLAG
Q4 25
Q3 25
Q2 25
$418.8K
Q1 25
$413.4K
Q4 24
$411.0K
Q3 24
$0
$4.2M
Q2 24
$0
$4.2M
Q1 24
$1.1M
$3.8M
Stockholders' Equity
ICU
ICU
PLAG
PLAG
Q4 25
$10.4M
$-2.2M
Q3 25
$11.5M
$-573.5K
Q2 25
$3.3M
$10.1M
Q1 25
$565.0K
$11.0M
Q4 24
$-2.2M
$11.7M
Q3 24
$-2.1K
$15.5M
Q2 24
$-6.9M
$16.5M
Q1 24
$-4.5M
$18.3M
Total Assets
ICU
ICU
PLAG
PLAG
Q4 25
$14.2M
$10.2M
Q3 25
$15.5M
$12.3M
Q2 25
$8.4M
$28.1M
Q1 25
$7.6M
$26.1M
Q4 24
$4.7M
$25.4M
Q3 24
$4.6M
$41.9M
Q2 24
$3.5M
$42.2M
Q1 24
$7.7M
$42.9M
Debt / Equity
ICU
ICU
PLAG
PLAG
Q4 25
Q3 25
Q2 25
0.04×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.27×
Q2 24
0.25×
Q1 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICU
ICU
PLAG
PLAG
Operating Cash FlowLast quarter
$-4.1M
$-1.8M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-343.4%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-3.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICU
ICU
PLAG
PLAG
Q4 25
$-4.1M
$-1.8M
Q3 25
$-3.8M
$697.5K
Q2 25
$-3.0M
$-1.7M
Q1 25
$-2.7M
$-346.7K
Q4 24
$-4.7M
$811.8K
Q3 24
$-5.0M
$948.0K
Q2 24
$-2.8M
$-943.7K
Q1 24
$-3.5M
$430.5K
Free Cash Flow
ICU
ICU
PLAG
PLAG
Q4 25
$-1.8M
Q3 25
$697.5K
Q2 25
$-1.7M
Q1 25
$-349.2K
Q4 24
$810.6K
Q3 24
$948.0K
Q2 24
$-945.0K
Q1 24
$424.3K
FCF Margin
ICU
ICU
PLAG
PLAG
Q4 25
-343.4%
Q3 25
90.4%
Q2 25
-185.2%
Q1 25
-41.5%
Q4 24
98.4%
Q3 24
64.9%
Q2 24
-104.5%
Q1 24
28.2%
Capex Intensity
ICU
ICU
PLAG
PLAG
Q4 25
0.9%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.3%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.2%
Q1 24
0.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons